Published in Int J Cardiol on September 20, 2010
Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J (2004) 2.85
Validation of the GRACE risk score for predicting death within 6 months of follow-up in a contemporary cohort of patients with acute coronary syndrome. Rev Esp Cardiol (2010) 2.78
[Clinical features and prognosis of patients with chronic cerebrovascular disease (ICBAR study)]. Rev Neurol (2011) 2.57
Patients with New York Heart Association class III heart failure may benefit with high flow nasal cannula supportive therapy: high flow nasal cannula in heart failure. J Crit Care (2013) 2.43
[Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. Rev Esp Cardiol (2006) 2.26
New evidence, new controversies: a critical review of the European Society of Cardiology 2010 clinical practice guidelines on atrial fibrillation. Rev Esp Cardiol (Engl Ed) (2011) 2.01
Cardiac troponin I and creatine kinase MB isoenzyme in patients with chronic renal failure. Nefrologia (2012) 1.96
A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J (2011) 1.67
Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes. Cardiovasc Res (2004) 1.60
Adiponectin is synthesized and secreted by human and murine cardiomyocytes. FEBS Lett (2005) 1.58
Usefulness of plasma cardiotrophin-1 in assessment of left ventricular hypertrophy regression in hypertensive patients. J Hypertens (2005) 1.53
Validation of the SAMe-TT2R2 score in a nationwide population of nonvalvular atrial fibrillation patients on vitamin K antagonists. Thromb Haemost (2015) 1.49
Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovasc Ther (2010) 1.48
Impact of new criteria for anticoagulant treatment in atrial fibrillation. Rev Esp Cardiol (2011) 1.44
Low levels of high-density lipoproteins cholesterol are independently associated with acute coronary heart disease in patients hospitalized for chest pain. Rev Esp Cardiol (Engl Ed) (2011) 1.43
[Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile]. Rev Esp Cardiol (2006) 1.42
Prevalence of chronic kidney disease in patients with or at a high risk of cardiovascular disease. Rev Esp Cardiol (2010) 1.41
Influence of the preimplantation QRS axis on responses to cardiac resynchronization therapy. Rev Esp Cardiol (2008) 1.40
[Gender differences in early reperfusion treatment after myocardial infarction]. Med Clin (Barc) (2007) 1.40
Association between renal function and cardiovascular disease in patients with left ventricular hypertrophy. VIIDA study. J Clin Hypertens (Greenwich) (2009) 1.40
[Hypertrophic cardiomyopathy in adult patients. Clinical course and prognostic factors in 119 patients]. Med Clin (Barc) (2004) 1.39
[Impact of blood pressure control on the ankle-brachial index in hypertensive patients]. Med Clin (Barc) (2012) 1.38
Multicenter randomized trial of a comprehensive hospital discharge and outpatient heart failure management program. Eur J Heart Fail (2004) 1.21
Differential prognostic effect of systolic blood pressure on mortality according to left-ventricular function in patients with acute heart failure. Eur J Heart Fail (2010) 1.12
Periannular complications in infective endocarditis involving prosthetic aortic valves. Am J Cardiol (2006) 1.11
[Pneumopericardium complicating bronchogenic carcinoma]. Rev Esp Cardiol (2002) 1.06
[Diabetes mellitus in cardiology practice in Spain. Survey by the Working Group on Heart and Diabetes regarding the importance of diabetes mellitus in relation with other cardiovascular diseases]. Rev Esp Cardiol (2004) 1.00
Periannular complications in infective endocarditis involving native aortic valves. Am J Cardiol (2006) 0.99
Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels: New Roles for Soluble RAGE. Eur J Heart Fail (2010) 0.99
Glycated albumin, a precursor of advanced glycation end-products, up-regulates NADPH oxidase and enhances oxidative stress in human endothelial cells: molecular correlate of diabetic vasculopathy. Diabetes Metab Res Rev (2010) 0.96
Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome. Rev Esp Cardiol (2010) 0.95
Pravastatin counteracts angiotensin II-induced upregulation and activation of NADPH oxidase at plasma membrane of human endothelial cells. J Cardiovasc Pharmacol (2010) 0.93
[Gender differences in adiponectin and leptin expression in epicardial and subcutaneous adipose tissue. Findings in patients undergoing cardiac surgery]. Rev Esp Cardiol (2006) 0.89
Coronary artery disease is associated with higher epicardial retinol-binding protein 4 (RBP4) and lower glucose transporter (GLUT) 4 levels in epicardial and subcutaneous adipose tissue. Clin Endocrinol (Oxf) (2012) 0.89
[Aldosterone receptor antagonist use after myocardial infarction. Data from the REICIAM registry]. Rev Esp Cardiol (2011) 0.88
Des-acyl ghrelin has specific binding sites and different metabolic effects from ghrelin in cardiomyocytes. Endocrinology (2010) 0.88
Consensus document for the detection and management of chronic kidney disease. Nefrologia (2014) 0.88
Morbidity and mortality among heart failure patients in Galicia, N.W. Spain: the GALICAP Study. Int J Cardiol (2008) 0.88
Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens (2009) 0.87
Left ventricular mass regression after aortic valve replacement with the new Mitroflow 12A pericardial bioprosthesis. J Heart Valve Dis (2006) 0.86
Predictive value of advanced glycation end products for the development of post-infarction heart failure: a preliminary report. Cardiovasc Diabetol (2012) 0.85
Short- and long-term results of a programme for the prevention of readmissions and mortality in patients with heart failure: are effects maintained after stopping the programme? Eur J Heart Fail (2005) 0.85
Current status of NADPH oxidase research in cardiovascular pharmacology. Vasc Health Risk Manag (2013) 0.85
Leptin does not induce hypertrophy, cell cycle alterations, or production of MCP-1 in cultured rat and mouse cardiomyocytes. Endocr Res (2005) 0.84
Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. Am J Cardiol (2009) 0.84
FHL2 expression and variants in hypertrophic cardiomyopathy. Basic Res Cardiol (2014) 0.84
Differences in medical treatment of chronic coronary heart disease patients according to medical specialities. Cardiovasc Ther (2009) 0.83
[Comparison of coronary risk estimates derived using the Framingham and REGICOR equations]. Rev Esp Cardiol (2005) 0.83
Burden of systemic hypertension in patients admitted to cardiology hospitalization units. Am J Cardiol (2011) 0.83
Usefulness of the fractional flow reserve derived by intracoronary pressure wire for evaluating angiographically intermediate lesions in acute coronary syndrome. Rev Esp Cardiol (2010) 0.83
Inflammation and apoptosis in hypertension. Relevance of the extent of target organ damage. Rev Esp Cardiol (Engl Ed) (2012) 0.83
Comments on the ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. Rev Esp Cardiol (Engl Ed) (2012) 0.82
[Myxoma extending from the superior vena cava to the right pulmonary artery]. Rev Esp Cardiol (2007) 0.82
Adiponectin and p53 mRNA in epicardial and subcutaneous fat from heart failure patients. Eur J Clin Invest (2013) 0.82
Oral anticoagulation in nonvalvular atrial fibrillation in clinical practice: impact of CHADS(2) score on outcome. Cardiology (2010) 0.82
Evidence for a role of advanced glycation end products in atrial fibrillation. Int J Cardiol (2011) 0.82
[Influence of sex on mortality in hospitalized patients with congestive heart failure and preserved or depressed systolic function]. Rev Esp Cardiol (2005) 0.81
[Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease]. Rev Esp Cardiol (2011) 0.81
Circulating biomarkers of collagen metabolism in arterial hypertension: relevance of target organ damage. J Hypertens (2013) 0.81
Infective endocarditis due to Streptococcus bovis in a series of nonaddict patients: clinical and morphological characteristics of 20 cases and review of the literature. Can J Cardiol (2003) 0.81
Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction. World J Cardiol (2012) 0.81
Influence of heart failure on nucleolar organization and protein expression in human hearts. Biochem Biophys Res Commun (2012) 0.81
Do myocardial perfusion SPECT and radionuclide angiography studies in adult patients with hypertrophic cardiomyopathy have prognostic implications? J Nucl Cardiol (2004) 0.80
Assessment of the markers of platelet and coagulation activation following transcatheter closure of atrial septal defects. Int J Cardiol (2005) 0.80
Comparison of effectiveness of high-dose intracoronary adenosine versus intravenous administration on the assessment of fractional flow reserve in patients with coronary heart disease. Am J Cardiol (2013) 0.80
Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis. J Psychiatr Res (2009) 0.80
Procyanidins from grape pomace are suitable inhibitors of human endothelial NADPH oxidase. J Cell Biochem (2012) 0.80
Relation of soluble receptor for advanced glycation end products to predict mortality in patients with chronic heart failure independently of Seattle Heart Failure Score. Am J Cardiol (2011) 0.80
[Magnitude and characteristics of residual lipid risk in patients with a history of coronary revascularization: the ICP-bypass study]. Rev Esp Cardiol (2011) 0.79
Comments on the ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation. Rev Esp Cardiol (Engl Ed) (2012) 0.79
[Knowledge and implementation of cardiovascular risk clinical practice guidelines by general practitioners and specialists]. Rev Esp Cardiol (2006) 0.79
Safety and efficacy of coronary drug-eluting stents in octogenarians. Rev Esp Cardiol (2009) 0.79
Diagnostic value of N-terminal pro-brain natriuretic peptide in pleural effusions of cardiac origin. Arch Bronconeumol (2011) 0.79
Evaluation of a multiplex real-time PCR assay for detecting pathogens in cardiac valve tissue in patients with endocarditis. Rev Esp Cardiol (2010) 0.79
Anticoagulation prescription in atrial fibrillation. Expert Opin Pharmacother (2011) 0.79
Trends in clinical profile and medical treatments of atrial fibrillation patients over the last 10 years. Rev Port Cardiol (2013) 0.79
Outcomes and safety of antithrombotic treatment in patients aged 80 years or older with nonvalvular atrial fibrillation. Am J Cardiol (2011) 0.78
Erectile dysfunction may improve by blood pressure control in patients with high-risk hypertension. Postgrad Med (2010) 0.78
A real-world perspective on the prevalence and treatment of heart failure with a reduced ejection fraction but no specific or only mild symptoms. Heart Fail Rev (2015) 0.78
Percutaneous coronary intervention in a patient with a CoreValve aortic valve prosthesis. Rev Esp Cardiol (2010) 0.78
Comments on the ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. A report of the Task Force of the Clinical Practice Guidelines Committee of the Spanish Society of Cardiology. Rev Esp Cardiol (Engl Ed) (2012) 0.78